Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2− advanced breast cancer: a review
Crossref DOI link: https://doi.org/10.1007/s10549-017-4560-6
Published Online: 2017-11-04
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freedman, Rachel A.
Tolaney, Sara M.
License valid from 2017-11-04